Implicor – Medicinal Product Register of Latvia

Metoprololi tartras, Ivabradinum

Search by the name of the active substance

Medicinal product name	Implicor 25 mg/7.5 mg film-coated tablets
Pharmaceutical form	Film-coated tablet
Strength	25 mg/7.5 mg
Information from the MAH on shortages	Not available predicted availability date: Jun 26, 2040
Legal status	Rx Prescription (Pr.)
Package leaflet	16-08-2022
Summary of product characteristics	16-08-2022
ATC code	C07FX05 – Beta blocking agents

Medicinal products (5)

Display only medicinal products with a declared price

Display only medicinal products available in wholesalers' stock

Availability of medicinal product	Wholesalers	Package size, content	Primary packaging	Maximum admissible pharmacy price (€ incl. VAT)	Product No.	Labelling
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N14 (25 mg/7,5 mg)	PVC/PVDC/Al blister		15-0125-01	Labelling text Aug 16, 2022
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N28 (25 mg/7,5 mg)	PVC/PVDC/Al blister		15-0125-02	Labelling text Aug 16, 2022
Not available (according to the information provided by wholesalers) predicted availability date: Jun 26, 2040	currently no information on availability from any wholesaler	N56 (25 mg/7,5 mg)	PVC/PVDC/Al blister	€ 64.41	15-0125-03	Labelling text Aug 16, 2022
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N98 (25 mg/7,5 mg)	PVC/PVDC/Al blister		15-0125-04	Labelling text Aug 16, 2022
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N112 (25 mg/7,5 mg)	PVC/PVDC/Al blister		15-0125-05	Labelling text Aug 16, 2022

Registration information

Marketing authorisation No.	15-0125
Date of authorisation	Jun 12, 2015
Marketing authorisation holder, country	Les Laboratoires Servier, France

Return to the results

Icon explanation

– Medicine is available
– Medicine is not available
– Distribution permitted for a limited time span
– Without a prescription
– Prescription medicine

– Medicine is listed on the Latvian National Health Service (NHS) list of state reimbursed medicines. (source of the information – the NHS)
– Reference medicine on the NHS List of state reimbursed medicines
– Lowest cost medicine within its therapeutic effectiveness class in cases where no reference medicine is available
- – Next lowest cost medicine after or (in ascending order)

Class A A (green): Suitable for the older persons. The medicinal substance can be used as in younger patients. Changes due to aging do not affect the dose or frequency of administration, and the adverse reaction profile is not different from that of younger patients.

Class B B (grey): There is little research evidence, practical experience or efficacy in older persons.

Class C C (yellow): Suitable for older persons, with specific cautions. The medicinal substance can be used by older persons, but the dose might either have to be reduced, or the frequency of administration decreased due to mild or moderate renal insufficiency or a significant risk of interactions or adverse reactions.

Class D D (red): Avoid use in older persons. Use is possible only in exceptional cases or on a one-off basis. Changes due to aging predispose older persons to adverse or dangerous reactions to the drug. The risk of adverse reactions typically exceeds the benefits.

Meds75+ data source is Finnish Medicines Agency Fimea (licensed under CC BY 4.0).
Data updated on Apr 19, 2024.